Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

EntreMed commences phase I trial of Angiostatin by s.c. injection

Dec. 18, 2000

Cytochroma collaborates with Johns Hopkins on vitamin D-related drug discovery

Dec. 18, 2000

ODAC unanimously recommends approval of Femara as first-line breast cancer treatment

Dec. 15, 2000

New progesterone receptor modulators continue to emerge from AHP/Ligand alliance

Dec. 15, 2000

Genetic Therapy constructs promising new antiangiogenic gene therapy

Dec. 15, 2000

Carborane-based retinoid receptor antagonists presented at recent scientific meeting

Dec. 15, 2000

Praecis seeks FDA approval of abarelix depot for prostate cancer

Dec. 15, 2000

Roche presents new antitumor agents acting on cyclin-dependent kinases

Dec. 14, 2000

Angstrom receives SBIR grant for development of uPAR antagonist

Dec. 14, 2000

Zycos begins phase II trial for treatment of cervical dysplasia

Dec. 14, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...